Insider · CIK 0001883986
Lara Meisner
Files at BCAX (Bicara Therapeutics Inc.). First filing Mar 18, 2025, latest Oct 1, 2025.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
BCAX: Bicara Therapeutics Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 33Weak | Bicara Therapeutics Inc. | $499k 33,807 shares | -100% | +59% from low-46% from high | |
| 12Weak | Bicara Therapeutics Inc. | $182k 15,829 shares | -100% | +31% from low-58% from high | |
| 11Weak | Bicara Therapeutics Inc. | $165k 15,829 shares | -100% | +8% from low-63% from high | |
| 25Weak | Bicara Therapeutics Inc. | $1.0M 79,146 shares | -100% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 29, 2025 | BCAX Bicara Therapeutics Inc. | MOption exercise Common Stock10b5-1 | +33,807 | $9.24 | $312k | 33,807 | Oct 1, 2025 |
| Sep 29, 2025 | BCAX Bicara Therapeutics Inc. | SOpen-market sale Common Stock10b5-1 | -33,807 | $14.75 | $499k | 0 | Oct 1, 2025 |
| Sep 29, 2025 | BCAX Bicara Therapeutics Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -33,807 | $0.00 | $0 | 101,423 | Oct 1, 2025 |
| Sep 15, 2025 | BCAX Bicara Therapeutics Inc. | MOption exercise Common Stock10b5-1 | +15,829 | $5.45 | $86k | 15,829 | Sep 17, 2025 |
| Sep 15, 2025 | BCAX Bicara Therapeutics Inc. | SOpen-market sale Common Stock10b5-1 | -15,829 | $11.49 | $182k | 0 | Sep 17, 2025 |
| Sep 15, 2025 | BCAX Bicara Therapeutics Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -6,085 | $0.00 | $0 | 54,769 | Sep 17, 2025 |
| Sep 15, 2025 | BCAX Bicara Therapeutics Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -9,744 | $0.00 | $0 | 87,699 | Sep 17, 2025 |
| Jun 16, 2025 | BCAX Bicara Therapeutics Inc. | MOption exercise Common Stock10b5-1 | +15,829 | $5.45 | $86k | 15,829 | Jun 18, 2025 |
| Jun 16, 2025 | BCAX Bicara Therapeutics Inc. | SOpen-market sale Common Stock10b5-1 | -15,829 | $10.43 | $165k | 0 | Jun 18, 2025 |
| Jun 16, 2025 | BCAX Bicara Therapeutics Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -6,085 | $0.00 | $0 | 60,854 | Jun 18, 2025 |
| Jun 16, 2025 | BCAX Bicara Therapeutics Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -9,744 | $0.00 | $0 | 97,443 | Jun 18, 2025 |
| Mar 14, 2025 | BCAX Bicara Therapeutics Inc. | MOption exercise Common Stock10b5-1 | +79,146 | $5.45 | $431k | 79,145 | Mar 18, 2025 |
| Mar 14, 2025 | BCAX Bicara Therapeutics Inc. | SOpen-market sale Common Stock10b5-1 | -48,526 | $12.69 | $616k | 30,620 | Mar 18, 2025 |
| Mar 14, 2025 | BCAX Bicara Therapeutics Inc. | SOpen-market sale Common Stock10b5-1 | -30,620 | $13.24 | $406k | 0 | Mar 18, 2025 |
| Mar 14, 2025 | BCAX Bicara Therapeutics Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -48,720 | $0.00 | $0 | 107,187 | Mar 18, 2025 |
| Mar 14, 2025 | BCAX Bicara Therapeutics Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -30,246 | $0.00 | $0 | 67,119 | Mar 18, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.